The Biostatistical Core's (BSC) primary goal remains the same as the last submission which is to closelyinteract with the Principal Investigators (Pis) of the three projects, the Investigators of the clinical sitesparticipating in Project I, the CLEARER trial, the Investigators of the clinical sites that will enroll patients inProject 2, the STOP-IT trial, and the Investigators in the basic science project, Project 3, TRUST, as wellas NIH personnel.
The specific aims of the BSC are to:1. Collaborate with all the investigators in the design of the investigations.2. Prepare programs for adaptive randomization for the CLEARER and STOP-IT trials and monitor each ona continuous basis.3. Provide a centralized information management system for collecting, entering, editing, storing, andanalyzing data. This includes development of data collection forms on a web-based data entry system, amanual of operations, quality control procedures, security and confidentiality of data, and long-term storagefor all projects. The web-based data-entry and communication system for the two SPOTRIAS clinical trials isa new addition from the previous five years.4. Produce scheduled reports to the clinical sites and also prepare reports to the Data and SafetyMonitoring Boards (DSMB).5. Analyze each trial data, Projects 1 and 2, in collaboration with the Investigators including performing aninterim analysis for Project 1, CLEARER.6. Analyze the data from Project 3 in collaboration with the Principal Investigator and other participatinginvestigators.7. Participate in the closeout of each clinical trial.8. Maintain the shared SPOTRIAS clinical subject database at UC for the SPOTRIAS Network andcoordinate regular submission of data to the Central Data Storage facility.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS044283-06
Application #
7506017
Study Section
Special Emphasis Panel (ZNS1-SRB-G (21))
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
6
Fiscal Year
2008
Total Cost
$159,953
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Lees, Kennedy R; Selim, Magdy H; Molina, Carlos A et al. (2016) Early Versus Late Assessment of Stroke Outcome. Stroke 47:1416-9
Kandadai, Madhuvanthi A; Mukherjee, Prithviraj; Shekhar, Himanshu et al. (2016) Microfluidic manufacture of rt-PA -loaded echogenic liposomes. Biomed Microdevices 18:48
Adeoye, Opeolu; Sucharew, Heidi; Khoury, Jane et al. (2015) Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial. Stroke 46:2529-33
Chaisinanunkul, Napasri; Adeoye, Opeolu; Lewis, Roger J et al. (2015) Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale. Stroke 46:2238-43
Adeoye, Opeolu; Sucharew, Heidi; Khoury, Jane et al. (2015) Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke 46:461-4
Kandadai, Madhuvanthi A; Meunier, Jason M; Hart, Kimberley et al. (2015) Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis. Transl Stroke Res 6:78-87
Brandler, Ethan S; Sharma, Mohit; Sinert, Richard H et al. (2014) Prehospital stroke scales in urban environments: a systematic review. Neurology 82:2241-9
Zahuranec, Darin B; Lisabeth, Lynda D; Sánchez, Brisa N et al. (2014) Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology 82:2180-6
Lu, A; Wagner, K R; Broderick, J P et al. (2014) Administration of S-methyl-L-thiocitrulline protects against brain injuries after intracerebral hemorrhage. Neuroscience 270:40-7
Adeoye, Opeolu; Knight, William A; Khoury, Jane et al. (2014) A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:e313-5

Showing the most recent 10 out of 46 publications